WallStSmart

Crocs Inc (CROX)vsMercadoLibre Inc. (MELI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MercadoLibre Inc. generates 768% more annual revenue ($35.18B vs $4.05B). CROX leads profitability with a 14.6% profit margin vs 5.3%. MELI appears more attractively valued with a PEG of 0.92. CROX earns a higher WallStSmart Score of 62/100 (C+).

CROX

Buy

62

out of 100

Grade: C+

Growth: 3.3Profit: 6.0Value: 8.7Quality: 5.5
Piotroski: 5/9Altman Z: 2.59

MELI

Buy

60

out of 100

Grade: C+

Growth: 7.3Profit: 6.0Value: 6.7Quality: 4.0
Piotroski: 2/9Altman Z: 1.35
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CROXUndervalued (+30.4%)

Margin of Safety

+30.4%

Fair Value

$118.93

Current Price

$112.48

$6.45 discount

UndervaluedFair: $118.93Overvalued
MELIUndervalued (+64.8%)

Margin of Safety

+64.8%

Fair Value

$5728.38

Current Price

$1897.37

$3831.01 discount

UndervaluedFair: $5728.38Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CROX2 strengths · Avg: 9.0/10
P/E RatioValuation
10.1x10/10

Attractively priced relative to earnings

Operating MarginProfitability
24.2%8/10

Strong operational efficiency at 24.2%

MELI5 strengths · Avg: 8.8/10
Revenue GrowthGrowth
49.8%10/10

Revenue surging 49.8% year-over-year

Market CapQuality
$96.19B9/10

Large-cap with strong market position

Return on EquityProfitability
23.8%9/10

Every $100 of equity generates 24 in profit

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Free Cash FlowQuality
$3.39B8/10

Generating 3.4B in free cash flow

Areas to Watch

CROX4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Debt/EquityHealth
1.223/10

Elevated debt levels

Return on EquityProfitability
-7.3%2/10

ROE of -7.3% — below average capital efficiency

EPS GrowthGrowth
-4.2%2/10

Earnings declined 4.2%

MELI4 concerns · Avg: 3.3/10
Price/BookValuation
12.3x4/10

Trading at 12.3x book value

Profit MarginProfitability
5.3%3/10

5.3% margin — thin

Debt/EquityHealth
1.683/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CROX

The strongest argument for CROX centers on P/E Ratio, Operating Margin. PEG of 1.39 suggests the stock is reasonably priced for its growth.

Bull Case : MELI

The strongest argument for MELI centers on Revenue Growth, Market Cap, Return on Equity. Revenue growth of 49.8% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bear Case : CROX

The primary concerns for CROX are Revenue Growth, Debt/Equity, Return on Equity.

Bear Case : MELI

The primary concerns for MELI are Price/Book, Profit Margin, Debt/Equity. A P/E of 51.8x leaves little room for execution misses. Debt-to-equity of 1.68 is elevated, increasing financial risk.

Key Dynamics to Monitor

CROX profiles as a value stock while MELI is a hypergrowth play — different risk/reward profiles.

CROX carries more volatility with a beta of 1.51 — expect wider price swings.

MELI is growing revenue faster at 49.8% — sustainability is the question.

MELI generates stronger free cash flow (3.4B), providing more financial flexibility.

Bottom Line

CROX scores higher overall (62/100 vs 60/100). MELI offers better value entry with a 64.8% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Crocs Inc

CONSUMER CYCLICAL · FOOTWEAR & ACCESSORIES · USA

Crocs, Inc. designs, develops, manufactures, markets and distributes casual lifestyle footwear and accessories for men, women and children. The company is headquartered in Broomfield, Colorado.

MercadoLibre Inc.

CONSUMER CYCLICAL · INTERNET RETAIL · USA

MercadoLibre, Inc. operates online trading platforms in Latin America. The company is headquartered in Buenos Aires, Argentina.

Want to dig deeper into these stocks?